128 related articles for article (PubMed ID: 1566486)
21. Xenogeneic bone marrow transplantation in the hamster-to-rat model prevents rejection of subsequently grafted hamster hearts.
Bouwman E; Scheringa M; Marquet RL
Transplant Proc; 1996 Apr; 28(2):681-2. PubMed ID: 8623342
[No Abstract] [Full Text] [Related]
22. Experimental cardiac xenografting with irradiation and intrathymic and intravenous xenogeneic cells.
Mohiuddin M; Shen Z; Goldstein C; Yokoyama H; DiSesa VJ
Transplant Proc; 1996 Apr; 28(2):673. PubMed ID: 8623337
[No Abstract] [Full Text] [Related]
23. Prolongation of cardiac xenograft survival by pre- and posttransplant splenectomy is associated with a decrease in anti-donor antibody titers.
Quarantillo P; Araneda D; Thomas F; Thomas J
Transplant Proc; 1993 Feb; 25(1 Pt 1):387-8. PubMed ID: 8438347
[No Abstract] [Full Text] [Related]
24. Tolerance to experimental cardiac allografts but not xenografts is induced after simultaneous neonatal intrathymic inoculation with allo and xenogeneic cells.
Shen Z; Mohiuddin M; Goldstein C; Yokoyama H; DiSesa VJ
Transplant Proc; 1996 Apr; 28(2):719-20. PubMed ID: 8623363
[No Abstract] [Full Text] [Related]
25. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
[No Abstract] [Full Text] [Related]
26. Role of splenectomy as adjunctive therapy in suppressing cardiac xenograft humoral immunity.
Carobbi A; Araneda D; Marchman W; Patselas T; Thomas F; Thomas J
Transplant Proc; 1992 Apr; 24(2):521-2. PubMed ID: 1566414
[No Abstract] [Full Text] [Related]
27. Timing of spleen activation in rats treated with cyclophosphamide (CyP): its role in a hamster-to-rat heterotopic heart xenotransplantation (HHX) model.
Catena M; Lattanzio G; Maggiano N; Musiani P; Ferla G
Transplant Proc; 1994 Jun; 26(3):1182-3. PubMed ID: 8029878
[No Abstract] [Full Text] [Related]
28. Mechanisms of protection from humoral rejection by a xenografted liver.
Celli S; Valdivia LA; Kelly RH; Sun H; Tsugita M; Pan F; Rao AS; Demetris AJ; Fung JJ; Starzl TE
Transplant Proc; 1995 Feb; 27(1):300-2. PubMed ID: 7533395
[No Abstract] [Full Text] [Related]
29. Cardiac hyperacute rejection in concordant xenograft combinations induced by immunization.
Wu GD; Cramer DV; Chapman FA; Wang HK; Hreha G; Ulker N; Makowka L
Transplant Proc; 1992 Apr; 24(2):691-2. PubMed ID: 1566483
[No Abstract] [Full Text] [Related]
30. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.
Lin Y; Sobis H; Vandeputte M; Waer M
Transplant Proc; 1994 Dec; 26(6):3202. PubMed ID: 7998115
[No Abstract] [Full Text] [Related]
31. Pretreatment of recipients (nude rat) with donor antigens leads to prolonged survival of hamster heart xenografts.
Tsugita M; Rao AS; Sun H; Wakizaka Y; Madariaga J; Pan F; Demetris AJ; Fung JJ; Starzl TE; Valdivia LA
Transplant Proc; 1996 Apr; 28(2):696-7. PubMed ID: 8623351
[No Abstract] [Full Text] [Related]
32. Augmentation of microchimerism with donor bone marrow infusion in hamster-to-rat heart xenograft recipients.
Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yoshioka S; Asahara T; Fukuda Y; Dohi K
Transplant Proc; 1999; 31(1-2):694-5. PubMed ID: 10083300
[No Abstract] [Full Text] [Related]
33. Graft survival in a hamster-to-rat heart transplantation model after treatment with total lymphoid irradiation, cyclosporine A, and a monoclonal anti-T-cell antibody.
Steinbrüchel DA; Madsen HH; Nielsen B; Kemp E; Larsen S; Koch C
Transplant Proc; 1990 Jun; 22(3):1088. PubMed ID: 2349667
[No Abstract] [Full Text] [Related]
34. [Induced tolerance to cardiac allografts with multiple intravenous injection of donor spleen cells].
Guo HW; Wu QY; Xie SS; Zhang QY; Yang XB; Shao MP
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):664-7. PubMed ID: 15329255
[TBL] [Abstract][Full Text] [Related]
35. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW
Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
[No Abstract] [Full Text] [Related]
36. Development of xenogeneic microchimerism correlated with graft outcome in hamster-to-rat heart xenotransplantation.
Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Fudaba Y; Fan XH; Tashiro H; Yoshioka S; Asahara T; Fukuda Y; Dohi K
Transplant Proc; 1998 Aug; 30(5):2484-5. PubMed ID: 9723548
[No Abstract] [Full Text] [Related]
37. Effect of simultaneous infusion of donor bone marrow on hamster-to-rat heart xenograft survival.
Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Yoshioka S; Asahara T; Fukuda Y; Dohi K
Transplant Proc; 1998 Nov; 30(7):3869-70. PubMed ID: 9838693
[No Abstract] [Full Text] [Related]
38. Prolongation of heart xenograft survival after liver hemoperfusion.
Amorosa L; Gugenheim J; Saint-Paul MC; Benzaken S; Mouiel J
Transplant Proc; 1990 Aug; 22(4):2002-3. PubMed ID: 2389509
[No Abstract] [Full Text] [Related]
39. The impact of xenograft rejection on future grafting.
Gannedahl G; Tufveson G
Transplant Proc; 1992 Feb; 24(1):276-8. PubMed ID: 1539281
[No Abstract] [Full Text] [Related]
40. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
Xiao F; Chong A; Foster P; Sankary H; McChesney L; Williams JM; Frieders D; Williams JW
Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
